Cargando…
Fuzi-Lizhong Decoction Alleviates Nonalcoholic Fatty Liver Disease by Blocking TLR4/MyD88/TRAF6 Signaling
BACKGROUND: Fuzi-Lizhong decoction (FLD) derives from the ancient Chinese Pharmacopoeia and has been clinically used for years. The present study aimed to investigate the activities and underlying mechanisms of FLD against nonalcoholic fatty liver disease (NAFLD). METHODS: In vivo studies were condu...
Autores principales: | Yang, Jiayao, Zhang, Ying, Yi, Hongfeng, Liao, Yan, Shu, Lei, Zhang, Shu, Li, Chenyu, An, Liu, Du, Nianlong, Shi, Zhaohong, Ma, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440633/ https://www.ncbi.nlm.nih.gov/pubmed/36065267 http://dx.doi.org/10.1155/2022/1637701 |
Ejemplares similares
-
Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
por: Yang, Jiayao, et al.
Publicado: (2020) -
Transcriptomic Analysis of Fuzi Lizhong Decoction for the Treatment of Stomach Ulcers
por: Xin, Yang, et al.
Publicado: (2020) -
Action Mechanism Underlying Improvement Effect of Fuzi Lizhong Decoction on Nonalcoholic Fatty Liver Disease: A Study Based on Network Pharmacology and Molecular Docking
por: Luo, Zheng, et al.
Publicado: (2022) -
Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
por: Chen, Junbin, et al.
Publicado: (2020) -
Antibiotics Attenuate Methamphetamine-Induced Hepatotoxicity by Regulating Oxidative Stress and TLR4/MyD88/Traf6 Axis
por: Chen, Li-Jian, et al.
Publicado: (2021)